about
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactu...
Read More
0.65
-0.02
(-2.99%)
1.7M
XNAS Volume
XNAS 31 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Humacyte Inc is on 11 Aug 2026 for the purpose of Humacyte Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Humacyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..